NM_001130823.3:c.4865-177C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001130823.3(DNMT1):​c.4865-177C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0624 in 152,250 control chromosomes in the GnomAD database, including 433 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.062 ( 433 hom., cov: 32)

Consequence

DNMT1
NM_001130823.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.27

Publications

5 publications found
Variant links:
Genes affected
DNMT1 (HGNC:2976): (DNA methyltransferase 1) This gene encodes an enzyme that transfers methyl groups to cytosine nucleotides of genomic DNA. This protein is the major enzyme responsible for maintaining methylation patterns following DNA replication and shows a preference for hemi-methylated DNA. Methylation of DNA is an important component of mammalian epigenetic gene regulation. Aberrant methylation patterns are found in human tumors and associated with developmental abnormalities. Variation in this gene has been associated with cerebellar ataxia, deafness, and narcolepsy, and neuropathy, hereditary sensory, type IE. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
DNMT1 Gene-Disease associations (from GenCC):
  • autosomal dominant cerebellar ataxia, deafness and narcolepsy
    Inheritance: AD, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen, PanelApp Australia, Genomics England PanelApp
  • hereditary sensory neuropathy-deafness-dementia syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 19-10133878-G-A is Benign according to our data. Variant chr19-10133878-G-A is described in ClinVar as Benign. ClinVar VariationId is 1259821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0955 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001130823.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNMT1
NM_001130823.3
MANE Select
c.4865-177C>T
intron
N/ANP_001124295.1P26358-2
DNMT1
NM_001318730.2
c.4826-177C>T
intron
N/ANP_001305659.1
DNMT1
NM_001379.4
c.4817-177C>T
intron
N/ANP_001370.1P26358-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNMT1
ENST00000359526.9
TSL:1 MANE Select
c.4865-177C>T
intron
N/AENSP00000352516.3P26358-2
DNMT1
ENST00000340748.8
TSL:1
c.4817-177C>T
intron
N/AENSP00000345739.3P26358-1
DNMT1
ENST00000592705.5
TSL:1
n.*4555-177C>T
intron
N/AENSP00000466657.1K7EMU8

Frequencies

GnomAD3 genomes
AF:
0.0624
AC:
9497
AN:
152132
Hom.:
433
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0161
Gnomad AMI
AF:
0.0724
Gnomad AMR
AF:
0.0454
Gnomad ASJ
AF:
0.0625
Gnomad EAS
AF:
0.00116
Gnomad SAS
AF:
0.0683
Gnomad FIN
AF:
0.0716
Gnomad MID
AF:
0.0570
Gnomad NFE
AF:
0.0974
Gnomad OTH
AF:
0.0556
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0624
AC:
9501
AN:
152250
Hom.:
433
Cov.:
32
AF XY:
0.0618
AC XY:
4600
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.0161
AC:
669
AN:
41558
American (AMR)
AF:
0.0453
AC:
693
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0625
AC:
217
AN:
3470
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5180
South Asian (SAS)
AF:
0.0686
AC:
331
AN:
4826
European-Finnish (FIN)
AF:
0.0716
AC:
759
AN:
10602
Middle Eastern (MID)
AF:
0.0612
AC:
18
AN:
294
European-Non Finnish (NFE)
AF:
0.0974
AC:
6625
AN:
68002
Other (OTH)
AF:
0.0555
AC:
117
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
450
899
1349
1798
2248
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
108
216
324
432
540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0779
Hom.:
305
Bravo
AF:
0.0572
Asia WGS
AF:
0.0260
AC:
89
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
5.1
DANN
Benign
0.40
PhyloP100
1.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs73013012; hg19: chr19-10244554; API